glp 1 agonist delayed gastric emptying Struggling with GLP-1 therapy side effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Side Effects provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GLP-1 medications safe to continue

AOM prescriptions for adolescents with obesity We found 270,170 adolescent patients who met our criteria of having obesity and no T2D

The FDA has raised red flags about unapproved versions of these medications

Beyond their metabolic benefits, growing evidence has highlighted their anti-inflammatory properties across a range of conditions characterized by chronic inflammation

Targeting mitochondrial quality control for diabetic cardiomyopathy: therapeutic potential of hypoglycemic drugs

The accumulated evidence from CVOTs has not only informed clinical practice guidelines but has also empowered healthcare providers with a valuable therapeutic option for T2D patients who have high cardiovascular risk

In our experience, transitioning directly to subcutaneous semaglutide 1 mg once weekly from another GLP-1 receptor agonist can be associated with nausea or GI disturbance